Rita P Loudermilk
Overview
Explore the profile of Rita P Loudermilk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
603
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Greenfield A, Loudermilk R, Bartley C, Chen C, Chen X, et al.
J Clin Invest
. 2024 Dec;
135(5).
PMID: 39739422
N-methyl-d-aspartate (NMDA) receptor-mediated autoimmune encephalitis (NMDAR-AE) frequently results in persistent sensory-motor deficits, especially in children, yet the underlying mechanisms remain unclear. This study investigated the long-term effects of exposure to...
2.
Delaveris C, Kong S, Glasgow J, Loudermilk R, Kirkemo L, Zhao F, et al.
Cell Chem Biol
. 2024 Aug;
31(9):1729-1739.e9.
PMID: 39178841
Foreign epitopes for immune recognition provide the basis of anticancer immunity. Due to the high concentration of extracellular adenosine triphosphate in the tumor microenvironment, we hypothesized that extracellular kinases (ectokinases)...
3.
Zamecnik C, Sowa G, Abdelhak A, Dandekar R, Bair R, Wade K, et al.
Nat Med
. 2024 Apr;
30(5):1300-1308.
PMID: 38641750
Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or diagnostic autoantibody remains elusive. In this study, the Department of Defense Serum Repository (DoDSR), a cohort of...
4.
Delaveris C, Kong S, Glasgow J, Loudermilk R, Kirkemo L, Zhao F, et al.
bioRxiv
. 2024 Apr;
PMID: 38562834
New epitopes for immune recognition provide the basis of anticancer immunity. Due to the high concentration of extracellular adenosine triphosphate in the tumor microenvironment, we hypothesized that extracellular kinases (ectokinases)...
5.
Zamecnik C, Sowa G, Abdelhak A, Dandekar R, Bair R, Wade K, et al.
medRxiv
. 2023 May;
PMID: 37205595
Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or diagnostic autoantibody remains elusive. Here, the Department of Defense Serum Repository (DoDSR), a cohort of over 10...
6.
Sabatino Jr J, Mittl K, Rowles W, Zamecnik C, Loudermilk R, Gerungan C, et al.
Mult Scler Relat Disord
. 2023 Jan;
70:104484.
PMID: 36608538
Background: Adequate response to the SARS-CoV-2 vaccine represents an important treatment goal in caring for patients with multiple sclerosis (MS) during the ongoing COVID-19 pandemic. Previous data so far have...
7.
Sabatino Jr J, Mittl K, Rowles W, Mcpolin K, Rajan J, Laurie M, et al.
JCI Insight
. 2022 Jan;
7(4).
PMID: 35030101
BACKGROUNDVaccine-elicited adaptive immunity is a prerequisite for control of SARS-CoV-2 infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target humoral and cellular immunity. A comprehensive comparison of the effects of...
8.
Sabatino Jr J, Mittl K, Rowles W, Mcpolin K, Rajan J, Zamecnik C, et al.
medRxiv
. 2021 Sep;
PMID: 34580672
Vaccine-elicited adaptive immunity is an essential prerequisite for effective prevention and control of coronavirus 19 (COVID-19). Treatment of multiple sclerosis (MS) involves a diverse array of disease-modifying therapies (DMTs) that...
9.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al.
Nature
. 2021 Aug;
596(7872):E8.
PMID: 34341540
No abstract available.
10.
Song E, Bartley C, Chow R, Ngo T, Jiang R, Zamecnik C, et al.
Cell Rep Med
. 2021 May;
2(5):100288.
PMID: 33969321
Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological symptoms, but the biological underpinnings of these phenomena are unknown. Through single-cell RNA sequencing (scRNA-seq) and cytokine analyses of cerebrospinal fluid...